Document is current
Any future updates will be listed below
-
Authors
Fujino, Takeshi
Goyama, Susumu
Sugiura, Yuki
Inoue, Daichi
Asada, Shuhei https://orcid.org/0000-0001-6116-7996
Yamasaki, Satoshi
Matsumoto, Akiko
Yamaguchi, Kiyoshi
Isobe, Yumiko
Tsuchiya, Akiho
Shikata, Shiori
Sato, Naru
Morinaga, Hironobu
Fukuyama, Tomofusa https://orcid.org/0000-0002-0709-3188
Tanaka, Yosuke
Fukushima, Tsuyoshi
Takeda, Reina
Yamamoto, Keita
Honda, Hiroaki
Nishimura, Emi K. https://orcid.org/0000-0002-5767-8045
Furukawa, Yoichi
Shibata, Tatsuhiro
Abdel-Wahab, Omar https://orcid.org/0000-0002-3907-6171
Suematsu, Makoto https://orcid.org/0000-0002-7165-6336
Kitamura, Toshio https://orcid.org/0000-0001-7855-1767
- License Information
-
More Information
Article History
Received: 5 December 2019
Accepted: 23 February 2021
First Online: 23 March 2021
Competing interests
: O.A.-W. has served as a consultant for H3B Biomedicine, Foundation Medicine Inc., Merck, and Janssen and serves on the scientific advisory board for Envisagenics Inc.; O.A.-W. has received personal speaking fees from Daiichi Sankyo. Other authors declare no competing interests.
